Immunocore Holdings plc (IMCR) Net margin 2021–2025
Immunocore Holdings plc (IMCR) net profit margin by fiscal year — reported net income divided by reported revenue.
-8.9%FY2025 · since FY2021: -4414.6% → -8.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.9% | +7.6 pp |
| FY2024 | -16.5% | +5.7 pp |
| FY2023 | -22.2% | +8.0 pp |
| FY2022 | -30.1% | +4384.5 pp |
| FY2021 | -4414.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMCR financial trends
IMCR RevenueIMCR Net incomeIMCR Gross profitIMCR Gross marginIMCR Operating incomeIMCR Operating marginIMCR Operating cash flowIMCR Free cash flowIMCR Capital expendituresIMCR Return on equityIMCR Stock buybacksIMCR Dividends paidIMCR Total assetsIMCR Total liabilitiesIMCR Shareholders’ equityIMCR overview →